-
Moderna Provides U.S. COVID-19 Vaccine Supply Update
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine in the United States, reporting that 45.4 million doses have been supplied to the U.S. Government to date. The Company continues to work closely with the U.S. Government to provide regular updates on supply and production. An additional 33.2 million doses of Moderna COVID-19 Vaccine have been filled in vials and are at various stages of final production and testing before release to the U.S. Government. Approximately 25.5 million doses of the ... (full story)